Board Meeting Intimation for The Meeting To Be Held On Saturday, I.E., 17Th October, 2026
Filed with BSE · · 1 page · English
Summary by 6ix AI
Hemo Organic Limited has announced a board meeting scheduled for a specific date to discuss financial results and other business matters. The meeting will focus on approving the un-audited financial results for a recent quarter and half-year period. This filing serves as a formal notification to the stock exchange regarding the upcoming meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/board-meeting-intimation-for-the-meeting-to-be-held-on-saturday-ie-17th-october-2026
Earlier from Hemo Organic
- Withdrawal Of Consent To Act As Company Secretary And Compliance Officer
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
- Appointment of Company Secretary and Compliance Officer
- Board Meeting Outcome for Outcome Of Board Meeting
Later from Hemo Organic
- Board Meeting Outcome for The Meeting Held Today I.E., Saturday, 17Th October, 2026
- Submission Of Un-Audited Financial Results Along With Limited Review Report Thereon For The Quarter And Half Year Ended 30Th September, 2026
- Statement On Deviation(S) / Variation(S) In Utilization Of Proceeds Raised Through Preferential Issue Of Convertible Warrants, Pursuant To Regulation 32 Of SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations) For The Quarter Ended On September 3
Follow Hemo Organic into a list and get an email when it puts out news.
Follow Hemo Organic